2Gregory SA, Webster JB, Chapman GD. Acute hepatitis induced by parenteral amiodarone[J]. Am J Med, 2002,113, (8): 254-255.
3Breuer H WM, Bossek W, Haferland C, et al. Amiodarone-induced severe hepatitis mediated by immunological mechanisms[J]. Int J Clin Eharmacol Ther 1998,36(6): 350-352.
2Mason JW. Amiodarone[J]. N Engl J Med, 1987, 316(8):455-466.
3McGovem B, Garan H, Kelly E, et al. Adverse reactions during treatment with amiodarone hydrochloride [J].BMJ, 1983, 287(6386):175-180.
4Harris L, McKenna WJ, Rowland E, et al. Side effects of long-term amiodarone therapy[J]. Circulation, 1983, 67(1):45-51.
5Fogoros RN, Anderson KP, Winkle RA, et al. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias [J]. Circulation 1983, 68(1):88-94.
6Rhodes A, Eastwood JB, Smith SA. Early acute hepatitis with parenteral amiodarone: A toxic effect of the vehicle? [J]. Gut 1993, 34(4):565-566.
7Pye M, Northcote RJ, Cobbe SM. Acute hepatitis alter parenteral amiodarone administration [J]. Br Heart J 1988, 59(6):690-691.
8Gregory SA, Webster JB, Chapman GD. Acute hepatitis induced by parenteral amiodarone[J]. Am J Med 2002,Med 2002, 113(15):254-255.
9Agozzino F, Picca M, Pelosi G. Acute hepatitis complicating intravenous amiodarone treatment[J]. Ital Heart J 2002, 3(11):686-688.
10Iliopoulou A, Giannakopoulos G, Mayrikakis M, et al.Reversible fulminant hepatitis following intravenous amiodarone loading [J]. Amiodarone hepatotoxicity. Int J Clin Pharmacol Ther 1999, 37(6): 312-313.
